The U.S. saw a slight increase in all abortions in 2025 and a more than 25% increase in chemical abortions obtained through telehealth, according to a report from the Guttmacher Institute.
There were 1,126,000 total abortions recorded in 2025 in the U.S., a less than 1% increase from 2024.
The report concedes, however, that the numbers are an “underestimate” of the total number of abortions nationally because abortions that are not provided by U.S. clinicians are not included.
The report also found that women traveled less frequently to obtain an abortion, coinciding with an increase in the number of chemical abortions obtained through telehealth provision.
“What’s really concerning is that we see a big increase in telehealth abortions,” Michael New, a scholar at The Catholic University of America, told “EWTN Pro-Life Weekly.” “They found that in states with abortion bans, over 91,000 women obtained abortions by telehealth. That was over a 25% increase from the previous year.”
“This really shows telehealth abortions are increasing abortion numbers,” New said. “Putting some limits on these telehealth abortions needs to be a top priority for pro-lifers.”
U.S. senators launch investigation into chemical abortion drug manufacturers
Five U.S. senators launched an investigation this week into chemical abortion drug manufacturers’ compliance with FDA safeguards, urging the FDA to take action on issues surrounding chemical abortions obtained through telehealth.
Led by Sen. Bill Cassidy, R-Louisiana, chair of the Senate Health, Education, Labor, and Pensions Committee, the senators in a March 25 letter pressed the FDA to “take immediate action,” citing concerns about women’s safety, fraud risks, and illegal sales of abortion drugs.
Cassidy and Sens. Steve Daines, R-Montana; James Lankford, R-Oklahoma; Cindy Hyde-Smith, R-Mississippi; and Lindsey Graham, R-South Carolina, requested records from abortion drug manufacturers Danco Laboratories, GenBioPro and Evita Solutions.
“It is unclear how the three FDA-approved chemical abortion drug manufacturers, Danco, GenBioPro, and Evita, ensure that prescribers and pharmacies comply with the few remaining [Mifepristone Risk Evaluation and Mitigation Strategy] requirements, especially when pills are sold online and without the in-person oversight of a medical professional,” the press release from the senators read.
U.S. Sen. Josh Hawley investigates abortion drug manufacturers
U.S. Sen. Josh Hawley launched his own investigation into abortion drug manufacturers last week, requesting records from Danco Laboratories and GenBioPro.
Hawley is concerned that drug companies profited from abortion pills while knowing the risks to women.
“Mounting evidence suggests that mifepristone poses grave risks to women,” Hawley wrote in the letter. “Yet your company has continued to profit from the widespread distribution of this drug even as serious questions have emerged about hemorrhage, infection, sepsis, and other dangerous complications associated with its use.”
Judge grants $1 murder bail, $2,000 for drug possession for Georgia woman after infant daughter dies
A Georgia judge granted a $1 bond for a woman accused of murder after introducing oxycodone into her infant daughter’s system and also ordered a $1,000 bond for each of two drug charges.
In late December 2025, Alexia Moore allegedly took eight misoprostol pills when she was between 22 and 24 weeks pregnant and “introduced illegal oxycodone into the infant’s system,” according to the arrest warrant. She gave birth prematurely to a baby girl who died within the hour.
Moore was arrested on March 4, facing one count of murder for unlawfully causing the death of the infant with “malice aforethought” and two drug-related charges.
Reports circulated blaming Georgia’s pro-life law for the arrest, but the Georgia law does not criminalize women who have abortions — no U.S. state does.
Ohio bill would recognize unborn babies with heartbeats with certificate of life
A recently proposed Ohio bill would require a certificate of life for unborn babies whose heartbeats are detectable.
The bill, backed by Republican state Rep. Jean Schmidt, would recognize unborn babies with detectable heartbeats through a certificate of life.
In Ohio, if an unborn baby dies, a death certificate is only required after 20 weeks’ gestation. The new bill would also move this requirement date to when the unborn baby has a heartbeat.
The bill would amend the law to “require the registration of all fetal deaths” and “the filing of a certificate of life after the detection of a fetal heartbeat.”
Another recent Ohio bill, backed by state Reps. Johnathan Newman and Jennifer Gross, would inform women who obtain abortion pills about abortion pill reversal.
“More than 8,000 babies have been saved from the abortion reversal pill,” Newman said. “This is important legislation that supports women and protects life.”
Missouri bishops urge prayer, fasting for passage of pro-life amendment
Missouri bishops are urging people to pray and fast for the passage of a pro-life amendment.
An amendment enshrining a right to abortion in the state constitution passed in 2024, eliminating pro-life laws and other safeguards.
“This year, Missourians will have the opportunity to restore those safeguards by voting for Amendment 3,” the bishops wrote. “The proposed constitutional amendment will protect women’s health and safety and restore protections for the unborn.”
The bishops encouraged the faithful to pray the nine-month “Novena for the Dignity of Human Life” on the 25th day of each month. The novena began in February.
“We ask the faithful and all people of goodwill to join us in prayer and fasting for the success of Amendment 3 and to support each human person from conception to natural death,” the bishops wrote.